跳至主要内容
临床试验/JPRN-UMIN000030248
JPRN-UMIN000030248招募中未知

Mapping of brain tau deposition in tauopathy by PET with [18F]PM-PBB3 - Mapping of brain tau deposition in tauopathy by PET with [18F]PM-PBB3

ational Institute of Radiological Sciences0 个研究点目标入组 200 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Subjects with neurodegenerative disease 1. Subjects with organic brain complications/disorders 2.Subjects with substance-related disorders 3.Subjects with severe physical complications/disorders or a history of such conditions 4. Subjects with claustrophobia 5. Pregnant, possibly pregnant or lactating women 6. From the standpoint of radiation exposure from a nuclear medicine scan, subjects who have participated in other nuclear medicine scans as healthy volunteers in the 6 months prior to the start of this study 7. Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study 2) Subjects with traumatic brain injury 1. Subjects with any organic brain disorder not due to traumatic brain injury 2. Subjects with severe physical complications/disorders or a history of such conditions 3. Subjects with claustrophobia 4. Pregnant, possibly pregnant or lactating women 5. From the standpoint of radiation exposure from a nuclear medicine scan, subjects who have participated in other nuclear medicine scans as healthy volunteers in the 6 months prior to the start of this study 6. Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study 3) Healthy volunteers 1. Subjects with organic brain complications/disorders 2. Subjects with substance-related disorders 3.Subjects with severe physical complications/disorders or a history of such conditions 4. Subjects with claustrophobia 5. Pregnant, possibly pregnant or lactating women 6. From the standpoint of radiation exposure from a nuclear medicine scan, subjects who have participated in other nuclear medicine scans as healthy volunteers in the 6 months prior to the start of this study 7. Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study 8. Subjects with tattoo 9. Subjects with metallic medical device in the body

研究者

发起方
ational Institute of Radiological Sciences

相似试验

已完成
不适用
Mapping of brain tau deposition in tauopathy by PET with [11C]PBB3Healthy volunteers 20 years of age or older at the time of obtaining consent Patients with mild cognitive impairment (MCI) 20 years of age or older at the time of obtaining consent Patients with Alzheimer&#39s disease (AD) 20 years of age or older at the time of obtaining consent Patients with corticobasal degeneration (CBD) 20 years of age or older at the time of obtaining consent Patients with progressive supranuclear palsy (PSP) 20 years of age or older at the time of obtaining consent Patients with frontotemporal dementia (FTD) 20 years of age or older at the time of obtaining consent Patients with familial Parkinson&#39s disease with the LRRK2 genetic mutation (PARK8)
JPRN-UMIN000009863ational Institute of Radiological Sciences124
招募中
不适用
[18F]THK-5351 PET imaging of tau deposits in neurological disorderscorticobasal syndrome, other neurodegenerative disorders, and normal volunteers
JPRN-UMIN000021819Tohoku University160
已完成
不适用
PET study of brain tau deposition in late onset psychosis using [11C]PBB3
JPRN-UMIN000017837ational Institute of Radiological Sciences57
进行中(未招募)
1 期
PET imaging study of the brain tau deposit in individuals with subjective cognitivedecline and mild cognitive impairment: FACEHBI cohort.Subjective cognitive impairment and mild cognitive decline in evaluation fordiagnosis of Alzheimer's Disease.
EUCTR2021-000473-83-ESFundació ACE-Institut Català de Neurociències Aplicades100
招募中
不适用
Detection of tau deposition in normal brain aging and neurodegenerative disorders using tau imaging with [C-11]PBB3 and PETHealthy volunteers and patients with neurodegenerative disorders
JPRN-UMIN000014087Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology70